One explanation of these data could be that high expression of either cyclin E1 or cyclin E2 could precipitate genome doubling, leading to genome doubled cancers with high CCNE1 or CCNE2 expression, as shown in Figure 1. The gene discussed is CCNE2; the disease is cancer.